ReNeuron Group plc (LON:RENE – Get Free Report)’s stock price passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 3.38 ($0.04) and traded as high as GBX 3.50 ($0.04). ReNeuron Group shares last traded at GBX 3.38 ($0.04), with a volume of 177,373 shares.
ReNeuron Group Trading Down 2.2 %
The stock has a market cap of £1.93 million, a P/E ratio of -37.50 and a beta of 0.67. The company has a current ratio of 1.51, a quick ratio of 2.02 and a debt-to-equity ratio of 14.25. The company has a 50-day moving average price of GBX 3.38 and a two-hundred day moving average price of GBX 3.61.
ReNeuron Group Company Profile
ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease.
Featured Articles
- Five stocks we like better than ReNeuron Group
- How to Use the MarketBeat Stock Screener
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- How to Buy Cheap Stocks Step by Step
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Short Selling: How to Short a Stock
- MarketBeat Week in Review – 6/24 – 6/28
Receive News & Ratings for ReNeuron Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReNeuron Group and related companies with MarketBeat.com's FREE daily email newsletter.
